PlumX Metrics
Embed PlumX Metrics

Indications and Outcome of Intravitreal Bevacizumab Injection in a Community Eye Hospital, Nepal

medRxiv
2024
  • 0
    Citations
  • 0
    Usage
  • 0
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Mentions
    1
    • News Mentions
      1
      • News
        1

Most Recent News

Indications and Outcome of Intravitreal Bevacizumab Injection in a Community Eye Hospital, Nepal

2024 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Angiogenesis Daily -- According to news reporting based on a preprint abstract, our

Article Description

Intravitreal bevacizumab(IVB) injection, is a humanized monoclonal antibody that has been in use for the treatment of retinal diseases, very cheaply, especially for developing countries like Nepal. This is a retrospective study designed to evaluate the indications and outcomes of IVB at Hetauda Community Eye Hospital from 2019 to 2022. In this study, among 247 patients including 260 eyes with a follow-up rate of 221 patients involving 234 eyes, the mean patient age was 64.4 years, with male predominance of 56.1%. Thus, IVB was used principally in the treatment of diabetic retinopathy, neovascular age-related macular degeneration, and branch retinal vein occlusion. The results indicated significant improvements in central macular thickness and visual acuity with respect to diabetic retinopathy, nAMD, and BRVO. The study thus puts forth the effectiveness of IVB in improving visual outcomes and reducing CMT in a resource-constrained setting; hence, its use should be implemented as a viable treatment option within such an environment.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know